• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic hits 52-week high on Q4, FY2013 results

Medtronic hits 52-week high on Q4, FY2013 results

May 22, 2013 By Brad Perriello

FLASH: Medtronic's Q4, 2012 profits slide

Medtronic (NYSE:MDT) shares peaked at a 52-week high yesterday after the world’s largest pure-play medical device company reported Wall Street-topping earnings per share for its fiscal 4th quarter and 2013.

Fridley, Minn.-based Medtronic logged Q4 profits of $969 million, or 95¢ per share, on sales of $4.56 billion during the 3 months ended April 26, for a bottom-line slide of 2.2% on top-line growth of 3.8%.

For the full year Medtronic reported profits of $3.47 billion, or $3.37 per share, on sales of $16.59 billion, representing a profit slide of 4.1% on sales growth of 2.5%.

Adjusted to exclude 1-time items, Q4 earnings per share were $1.10, 7¢ above expectations on The Street. Full-year adjusted EPS were $3.75, 6¢ above Wall Street.

That was enough to send MDT shares to a yearlong high of $53.83 apiece yesterday along the way to a $52.35 close, up 4.9%.

"These 4th-quarter results were a strong finish to a solid fiscal year, and more importantly, represented another step toward our goal of delivering consistent and dependable growth, and I am proud of the performance of our entire global team," chairman & CEO Omar Ishrak said in prepared remarks. "We continue to lead in the global medical technology marketplace, and we are making meaningful progress in globalizing our strategies and operations as well as strengthening our clinical and economic value propositions for our customers and partners."

Medtronic said it expects fiscal 2014 sales growth of 3%-4%, with diluted EPS of $3.80-$3.85 and adjusted EPS growth of 6%-8%.

Company officials also said that Medtronic is about ⅔ of the way through a restructuring program that includes layoffs for 2,000 workers worldwide, company officials said today, with about half of the job cuts coming in the U.S.

CFO Gary Ellis told analysts during a conference call that roughly ½ of the layoffs will take place in the U.S. as Medtronic consolidates its manufacturing operations, the Pioneer Press reported. The company is about ⅔ of the way through the job cuts plan and is actually adding positions in some areas, a spokeswoman told the newspaper. The cuts are aimed at paring $200 million to $225 million from Medtronic’s annual budget, Ellis said.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2013, Q1

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy